Contribute
Present at WCI 2025
Submit an abstract to be considered for oral or poster presentation alongside the field's most distinguished experts.
Event Partner
Dexec Event Planner, Event Partner & Travel Desk
WCI 2025 features 120+ world-class scientists and clinicians from across the globe — the visionaries defining itch research in 2025 and beyond.
University of Heidelberg
Neuroimmune Pathways in Chronic Itch
Harvard Medical School
Advances in Targeted Therapies
Clinical Research Institute
Patient-Centered Treatment Models
Tokyo Medical University
Translational Itch Research
University of Heidelberg · Germany
🔬 Neuroimmune Pathways in Chronic Itch
Leading researcher in neuroimmune mechanisms of itch with over 50 peer-reviewed publications. Director of the Heidelberg Itch Research Centre.
Harvard Medical School · USA
💊 Advances in Targeted Therapies for Pruritus
World authority in targeted biologics for inflammatory skin diseases. PI in 12 Phase III clinical trials. AAD Research Award 2022.
Clinical Research Institute · Spain
🩺 Patient-Centered Treatment Models
Specialist in quality-of-life outcomes in chronic pruritic conditions. Pioneer of the patient-reported outcomes framework adopted by the EDF in 2021.
Tokyo Medical University · Japan
🔄 Translational Itch Research & Innovation
Expert in translational itch models and novel antipruritic drug candidates. Lead investigator on Japan-EU collaborative pruritus research programme.
Paris Descartes University · France
🧬 Immunology of Atopic Dermatitis-Associated Itch
Leading immunologist specialising in Th2/Th22 pathways in AD. Active contributor to European clinical guidelines for atopic dermatitis management.
AIIMS · India
🌏 Itch in Tropical Dermatoses
Pioneer in pruritic tropical skin conditions. Research focuses on accessible, affordable therapeutic strategies for low-resource clinical settings.
Stanford University · USA
🧠 Central Sensitisation in Chronic Pruritus
Neuroscientist studying CNS contributions to itch chronification. Key publications on glial cell signalling and spinal cord itch circuits.
University Hospital Zurich · Switzerland
⚗️ JAK Inhibitors in Pruritic Conditions
Dermatologist and clinical trialist with extensive experience in JAK/STAT pathway inhibition for pruritic diseases. Contributed to three approved JAK inhibitors in Europe.
University of Melbourne · Australia
🔬 Mast Cell Biology in Itch Signalling
Expert in mast cell-nerve interactions and histamine-independent pruritus. Co-lead of the ANZ Pruritus Biobank Project.
University of Milan · Italy
💼 Regulatory Pathways for Antipruritic Drugs
Former EMA scientific advisor leading regulatory strategy for novel antipruritic agents. Expert in accelerated approval pathways and biomarker validation.
Full faculty — 120+ confirmed speakers — available in the congress app from August 2025.
Submit an abstract to be considered for oral or poster presentation alongside the field's most distinguished experts.
Dexec Event Planner, Event Partner & Travel Desk